Significant changes are ahead for clinical research in China. The Public Consultation Notice for Policies to Encourage Innovation and Reform in Regulation of Drug and Medical Device Clinical Testing was released by the CFDA on 11 May, 2017. These proposed changes herald an exciting new era for drug and device development. If implemented in full, […]
Read More
George Clinical welcomes the development of the INVICTUS program which was launched at the World Heart Federation’s World Congress of Cardiology and Cardiovascular Health recently. The study, supported by Bayer AG and endorsed by the World Heart Federation, will be conducted by George Clinical in China and reinforces the importance of scientific leadership when undertaking […]
Read More
A recent article published in PharmAsia News highlighted the results of ground-breaking research, published in The New England Journal of Medicine (NEJM), that showed a lower dose of intravenous alteplase can reduce bleeds in the brain and improve survival rates in patients with acute ischemic stroke. While the results of ENCHANTED, a predominantly Asian study, […]
Read More
New legislation has taken into effect which simplifies the Hong Kong regulatory process for clinical trial application in that country
Read More
Chronic obstructive pulmonary disorder (COPD) is now the third most frequent cause of death in the world; however the cause of this disease for a substantial proportion of patients remains unknown.
Read MoreGeorge Clinical has had a long history in Malaysia, where we first started working in 1999. In particular, we have established networks of cardiovascular, diabetes and renal Investigators in this multiracial country which has good clinical trial infrastructure. Office Locations: Level 15.01, 1 First Avenue, 2A Dataran Bandar Utama, Bandar Utama Damansara, 47800 Petaling […]
Read More
George Clinical East Asia is headquartered in Hong Kong. From this location, we oversee our on the ground operations in Hong Kong, Taiwan and Malaysia; whilst enabling coverage of other South East Asian countries such as Singapore and Philippines. Office Locations: Units 4305-06, Tower 1, Metroplaza, 233 Hing Fong Road, Kwai Fong, New Territories […]
Read MoreGeorge Clinical India is headquartered in Bengaluru. From this location, we oversee our operations throughout India which includes an office in Hyderabad and a number of home based personnel. India has a highly skilled, English speaking workforce within an established clinical trials industry. With its large, rapidly urbanizing population, India offers significant patient pools. […]
Read More
George Clinical China is headquartered in Beijing, where we are co-located with our partner in research, The George Institute. From this location, we oversee our operations throughout China which includes an office in Shanghai and a number of home based personnel. With China fast becoming the second largest pharmaceutical market in the world, along with its […]
Read More
George Clinical is an Australian owned organization headquartered in Sydney, Australia. In Sydney, we are co-located with our partner in research, The George Institute, a world leading medical research institute. From this location, we oversee our operations throughout Asia-Pacific. Australia is an attractive place to conduct clinical research with an efficient regulatory process, highly experienced […]
Read More
